Book Closure For Annual General Meeting And Payment Of Dividend.
Book Closure for Annual General Meeting and payment of dividend.25-05-2018
25-05-2018
Book Closure For Annual General Meeting And Payment Of Dividend
Book Closure for Annual General Meeting and payment of dividend25-05-2018
Board Meeting-Outcome of Board Meeting
Audited Financial Results along with Audit Report of the Statutory Auditors for the quarter / year ended on March 31, 2018.25-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Dutasteride and Tamsulosin Hydrochloride Capsules25-05-2018
Board Meeting On May 24, 2018.
Further to our earlier intimation dated May 4, 2018 regarding board meeting, the Board of Directors [the Board] shall also consider the following proposals: (i) to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR, subject to approval of the shareholders,...21-05-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to the earlier communication today on the captioned subject, please consider the date as May 25, 2018, which was inadvertently mentioned as May 28, 2018.16-05-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned investor interaction through a teleconference call at 4:00 p.m. on Friday, May 28, 2018 for post results Q&A; session.16-05-2018
Zydus Cadila gets USFDA nod for Carbidopa tablets
Zydus Cadila has received final approval from the US health regulator to market Carbidopa tablets, used for treating Parkinson's symptoms which incl10-05-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Carbidopa Tablets10-05-2018